These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 37026260)

  • 1. Autophagy in dry eye disease: Therapeutic implications of autophagy modulators on the ocular surface.
    Jeyabalan N; Pillai AM; Khamar P; Shetty R; Mohan RR; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1285-1291. PubMed ID: 37026260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Molecular Mechanisms Responsible for Tear Hyperosmolarity-Induced Pathological Changes in the Eyes of Dry Eye Disease Patients.
    Harrell CR; Feulner L; Djonov V; Pavlovic D; Volarevic V
    Cells; 2023 Dec; 12(23):. PubMed ID: 38067183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLRP3 Inflammasome as a Potential Therapeutic Target in Dry Eye Disease.
    Zhuang D; Misra SL; Mugisho OO; Rupenthal ID; Craig JP
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive dry eye therapy: overcoming ocular surface barrier and combating inflammation, oxidation, and mitochondrial damage.
    Xia Y; Zhang Y; Du Y; Wang Z; Cheng L; Du Z
    J Nanobiotechnology; 2024 May; 22(1):233. PubMed ID: 38725011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular Pharmacology of Tear Film, Dry Eye, and Allergic Conjunctivitis.
    Gulati S; Jain S
    Handb Exp Pharmacol; 2017; 242():97-118. PubMed ID: 27913889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear biomarkers in dry eye disease: Progress in the last decade.
    Kumar NR; Praveen M; Narasimhan R; Khamar P; D'Souza S; Sinha-Roy A; Sethu S; Shetty R; Ghosh A
    Indian J Ophthalmol; 2023 Apr; 71(4):1190-1202. PubMed ID: 37026250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal autophagy and ocular surface inflammation: A new perspective in dry eye.
    Ma S; Yu Z; Feng S; Chen H; Chen H; Lu X
    Exp Eye Res; 2019 Jul; 184():126-134. PubMed ID: 31018117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trehalose augments autophagy to mitigate stress induced inflammation in human corneal cells.
    Panigrahi T; Shivakumar S; Shetty R; D'souza S; Nelson EJR; Sethu S; Jeyabalan N; Ghosh A
    Ocul Surf; 2019 Oct; 17(4):699-713. PubMed ID: 31412290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunological Basis of Dry Eye Disease and Current Topical Treatment Options.
    Periman LM; Perez VL; Saban DR; Lin MC; Neri P
    J Ocul Pharmacol Ther; 2020 Apr; 36(3):137-146. PubMed ID: 32175799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteoglycan 4 (PRG4) expression and function in dry eye associated inflammation.
    Menon NG; Goyal R; Lema C; Woods PS; Tanguay AP; Morin AA; Das N; Jay GD; Krawetz RJ; Dufour A; Shapiro LH; Redfern RL; Ghosh M; Schmidt TA
    Exp Eye Res; 2021 Jul; 208():108628. PubMed ID: 34048779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Video display terminal use and dry eye: preventive measures and future perspectives.
    Kamøy B; Magno M; Nøland ST; Moe MC; Petrovski G; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Nov; 100(7):723-739. PubMed ID: 35122403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A distinct cytokines profile in tear film of dry eye disease (DED) patients with HIV infection.
    Agrawal R; Balne PK; Veerappan A; Au VB; Lee B; Loo E; Ghosh A; Tong L; Teoh SC; Connolly J; Tan P
    Cytokine; 2016 Dec; 88():77-84. PubMed ID: 27585367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. sPLA
    Wei Y; Asbell PA
    Exp Eye Res; 2020 Dec; 201():108209. PubMed ID: 33011237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Subtle Role of Para-inflammation in Modulating the Progression of Dry Eye Disease.
    Rolando M; Barabino S
    Ocul Immunol Inflamm; 2021 May; 29(4):811-816. PubMed ID: 34003707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction.
    Ramos-Llorca A; Scarpellini C; Augustyns K
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [If Artificial Tears Aren't Enough. The Importance of Inflammatory Processes in Dry Eye Disease. Practical Aspects of an Anti-Inflammatory Therapy of Dry Eye Disease].
    Pleyer U; Geerling G; Schrader S; Jacobi C; Kimmich F; Messmer E
    Klin Monbl Augenheilkd; 2020 May; 237(5):655-668. PubMed ID: 32434249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining Dry Eye from a Clinical Perspective.
    Tsubota K; Pflugfelder SC; Liu Z; Baudouin C; Kim HM; Messmer EM; Kruse F; Liang L; Carreno-Galeano JT; Rolando M; Yokoi N; Kinoshita S; Dana R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.